26.01.2025, 1143 Zeichen

Porr: German rail technology company Vossloh AG said on Wednesday that it has awarded an order from Austrian construction group PORR as part of the British high-speed rail project High Speed 2 (HS2). Vossloh will supply rail fastening systems for the slab track on the line between London and Birmingham for the end customer HS2 Ltd. The order has a volume of over €30 million and covers the period from 2025 to 2027.
Österreichische Post: weekly performance: 0.34%

Valneva: Austrian/French Valneva today announced positive results for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different dose levels of its single-shot chikungunya vaccine, IXCHIQ^®, in 304 children. Partially funded by the Coalition for Epidemic Preparedness Innovations (CEPI), with support from the European Union, the trial is intended to support a pivotal Phase 3 study in children, which the Company expects to initiate in the fourth quarter of 2025, with the objective to extend the product label to this age group.
Valneva: weekly performance: 9.65%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (22/01/2025)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1122: ATX deutlich fester, FACC resilient, Kontron sieht sich günstig und Private Equity vs. Neobroker-Depots

Bildnachweis

Aktien auf dem Radar:Mayr-Melnhof, CPI Europe AG, Semperit, Austriacard Holdings AG, EuroTeleSites AG, Zumtobel, Lenzing, ATX, ATX Prime, ATX TR, voestalpine, Wienerberger, Bajaj Mobility AG, ATX NTR, OMV, Addiko Bank, Andritz, AT&S, Erste Group, Frequentis, Gurktaler AG VZ, Reploid Group AG, RBI, Uniqa, VIG, Athos Immobilien, BKS Bank Stamm, Oberbank AG Stamm, Marinomed Biotech, Amag, CA Immo.

---